Drugs / oestriol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00648310 | Jan 2004 → Dec 2007 | overactive bladder | University of Insubria | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05562518 Comparator | Mar 2022 → Mar 2026 overdue | breast cancer, postmenopausal atrophic vaginitis | University Hospital, Ghent | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | oestriol | “both tolterodine ER 4 mg and concomitant oestriol cream application once daily” PMID 18584946 ↗ Jun 20081“locally administered estrogen (oestriol)” NCT05562518 ↗ |
| Route | Topical | “oestriol cream application once daily” PMID 18584946 ↗ Jun 2008 |